Patents by Inventor Jesus BERMEJO

Jesus BERMEJO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROADM AND/OR HISTONES AS MARKERS INDICATING AN ADVERSE EVENT
    Publication number: 20210285968
    Abstract: The present invention relates to diagnosis, prognosis, risk assessment, and/or risk stratification of an adverse event, particularly mortality, of a subject. The invention relates to a method that comprises determining a level of proadrenomedullin (proADM) in a sample of said subject, and wherein said level of proADM is indicative of said adverse event of said subject, wherein said level of proADM is compared to a reference level of proADM; and wherein said adverse event of said subject is identified based on the comparison. The invention further relates to kits for carrying out the methods of the invention.
    Type: Application
    Filed: May 21, 2021
    Publication date: September 16, 2021
    Inventors: Darius Cameron WILSON, Jesus BERMEJO, David ANDALUZ, Dolores CALVO
  • ProADM and/or histones as markers indicating an adverse event
    Patent number: 11041867
    Abstract: The present invention relates to diagnosis, prognosis, risk assessment, and/or risk stratification of an adverse event, particularly mortality, of a subject. The invention relates to a method that comprises determining a level of proadrenomedullin (proADM) in a sample of said subject, and wherein said level of proADM is indicative of said adverse event of said subject, wherein said level of proADM is compared to a reference level of proADM; and wherein said adverse event of said subject is identified based on the comparison. The invention further relates to kits for carrying out the methods of the invention.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: June 22, 2021
    Assignee: B.R.A.H.M.S GmbH
    Inventors: Darius Cameron Wilson, Jesus Bermejo, David Andaluz, Dolores Calvo
  • PROADM AND/OR HISTONES AS MARKERS INDICATING AN ADVERSE EVENT
    Publication number: 20200081018
    Abstract: The present invention relates to diagnosis, prognosis, risk assessment, and/or risk stratification of an adverse event, particularly mortality, of a subject. The invention relates to a method that comprises determining a level of proadrenomedullin (proADM) in a sample of said subject, and wherein said level of proADM is indicative of said adverse event of said subject, wherein said level of proADM is compared to a reference level of proADM; and wherein said adverse event of said subject is identified based on the comparison. The invention further relates to kits for carrying out the methods of the invention.
    Type: Application
    Filed: February 1, 2018
    Publication date: March 12, 2020
    Inventors: Darius Cameron WILSON, Jesus BERMEJO, David ANDALUZ, Dolores CALVO